Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Find Roth IRA index funds with the lowest fees to keep more of your returns. Compare expense ratios and pick a cost-efficient fund for long-term growth.
27,085 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Analysts say cheap power, vast manufacturing, and a surge in open-source AI development could make China the big winn...
Anthropic reports an unprecedented 80-fold increase in annualized usage for Q1, fueling a rapid expansion that includ...
As the first-quarter report for Innovate lands, investors eye more than just the top line. This guide breaks down wha...
A fresh modeling study puts the economic toll of long COVID at over $8 billion from 2025 to 2027, driven largely by l...
Tesla faces a pivotal 2H 2026. This guide breaks down the catalysts, the risks, and practical steps investors can tak...
A contrarian pick in the under-$10 pile is showing improving margins and debt relief, even as investors overlook it. ...
Trading on world prediction markets before kickoff has eclipsed $2 billion, with Spain and France trading as the lead...
A high-stakes summer clash for American attention pits the NBA Finals against the USMNT World Cup debut on home soil,...
In June 2026, Bitcoin traders face a new threat: boredom. CryptoQuant sees a protracted lull in demand as the real ri...
A landmark housing bill cleared Congress this week, promising to ease rents and expand homebuilding. President Trump ...
Memory demand tied to AI and data centers has Micron at a pivotal moment. This guide breaks down whether micron stock...